Skip to content

Asset turnover at other companies

Abbott logo
AbbottABT
0.5×-0.1×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.4×0.0×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.4×0.0×
Danaher logo
DanaherDHR
0.3×0.0×
Agilent Technologies logo
Agilent TechnologiesA
0.6×0.0×
Revvity logo
RevvityRVTY
0.2×0.0×

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Calculated from Bio-Rad Laboratories, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s asset turnover?
Bio-Rad Laboratories, Inc. (BIO.B) reported asset turnover of 0.3× in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s asset turnover changed year-over-year?
Bio-Rad Laboratories, Inc.'s asset turnover increased by 16.8% year-over-year, from 0.2× to 0.3×.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s asset turnover has grown at a 1.3% compound annual growth rate (CAGR), from 0.2× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.